CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...
Pulse oximetry, which directly monitors the patient's oxygenation, came into its own as standard medical practice 20 ...
The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Toronto-based Cedara Software, a Merge Healthcare company and an independent developer of medical software technologies ...
One of the major dilemmas faced by clinicians in the Intensive Care Unit (ICU) is the determination of volume status and ...
Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”
AngioDynamics, Inc. has announced FDA 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) ...
Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration.
GE Healthcare has launched its new LightSpeed VCT XT, the industry’s first CT scanner that maintains outstanding image ...
An implantable technology to control high blood pressure in patients not responding to available medicines has ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during ...
An innovative lead insulation material for cardiac leads used with pacemakers and ICDs is now FDA approved and available ...
November 2006 - Toshiba America Medical Systems, Inc. has announced a new partnership with CVCTA Education and San ...